BT

Active Biotech AB publFRA Active Biotech Stock Report

Last reporting period 31 Dec, 2023

Updated 13 Nov, 2024

Last price

Market cap $B

0.011

Micro

Exchange

XFRA - Deutsche Boerse AG

BTPC.F Stock Analysis

BT

Uncovered

Active Biotech AB publ is uncovered by Eyestock quantitative analysis.

Market cap $B

0.011

Dividend yield

Shares outstanding

264.89 B

Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

View Section: Eyestock Rating